Journal of pharmaceutical sciences
Development and characterization of low molecular weight heparin-triethanolamine cream: Skin permeability and antithrombotic efficacy.
Masayori Hagimori, Seitaro Kamiya
Published: 202510.1016/j.xphs.2025.104078
Abstract
Heparin's coagulation factor inhibitory activity varies depending on its molecular size. Low-molecular-weight heparin (LMWH), which has fewer side effects, such as bleeding, compared to unfractionated heparin, has attracted attention. To develop a LM…
Preview only. Read the full abstract at the source